SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril

Although the clinical manifestation of COVID-19 is mainly respiratory symptoms, approximately 20% of patients suffer from cardiac complications. COVID-19 patients with cardiovascular disease have higher severity of myocardial injury and poor outcomes. The underlying mechanism of myocardial injury ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaohan, Fan, Wenxia, Sun, Jing, Yang, Jiaqing, Zhang, Yanjun, Wang, Qian, Li, Pingchao, Zhang, Yudi, Zhang, Shengnan, Li, Heying, Wang, Jianhua, Feng, Liqiang, Zhao, Jincun, Chen, Ling, Qu, Linbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191704/
https://www.ncbi.nlm.nih.gov/pubmed/37207821
http://dx.doi.org/10.1016/j.antiviral.2023.105636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191704/
https://www.ncbi.nlm.nih.gov/pubmed/37207821
http://dx.doi.org/10.1016/j.antiviral.2023.105636

Ejemplares similares